Kathryn Wagner, MD PhD, is Vice President and Global Head of Neuromuscular Disease at F. Hoffmann La Roche. Previously, she served as Director of the Center for Genetic Muscle Disorders at The Kennedy Krieger Institute for more than 20 years. She was also a Professor for the Department of Neurology and Neuroscience at The Johns Hopkins School of Medicine in Baltimore, where she conducted clinical trials in muscular dystrophy and cared for patients with FSHD. Dr. Wagner’s clinical interest is in neuromuscular and neurogenetic diseases, with a special emphasis on hereditary muscle diseases.
Additional positions included her role as co-director of an NIH-funded Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center targeting modulation of muscle growth for muscular dystrophies. She was also a Principal Investigator in the NIH NICHD-funded Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center for FSHD co-directed by Dr. Charles Emerson Jr. at Boston Biomedical Research Institute. Dr. Wagner led the muscle biopsy tissue collection effort at the Wellstone Center.